Cite
MLA Citation
Peter H. O'Donnell et al.. “Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108.” Cancer, vol. 126, no. 2, 2020, pp. 432–443. http://access.bl.uk/ark:/81055/vdc_100099160176.0x000061